Angiogenesis as a new target for cancer treatment

Mayumi Ono, Hiroto Izumi, Shigeo Yoshida, Daisuke Goto, Sei Ichiro Jimi, Naoyuki Kawahara, Tadahisa Shono, Shin Ushiro, Masahiro Ryuto, Kimitoshi Kohno, Yasafumi Sato, Michihiko Kuwano

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Neovascularization is often required for rapid growth of solid tumors and also limits vascular metastasis of tumor cells. Neovascularization-targeting agents are a recent innovation that may be a novel means of anticancer therapy. These antiangiogenic drugs have been developed by targeting cell proliferation of vascular endothelial cells, basement-membrane-degrading enzymes, angiogenic factors/receptors, extracellular matrix, angiogenesis signaling, and cell-cell/cell-matrix interactions. In this report, we describe how tumor angiogenesis occurs and how antiangiogenic agents are developed.

Original languageEnglish
JournalCancer Chemotherapy and Pharmacology, Supplement
Volume38
Publication statusPublished - Aug 23 1996

Fingerprint

Neoplasms
Angiogenesis Inhibitors
Angiogenesis Inducing Agents
Basement Membrane
Cell Communication
Blood Vessels
Endothelial Cells
Cell Proliferation
Cell Membrane
Neoplasm Metastasis
Enzymes
Growth
Pharmaceutical Preparations
Therapeutics
extracellular matrix receptor

All Science Journal Classification (ASJC) codes

  • Oncology
  • Pharmacology
  • Cancer Research

Cite this

Ono, M., Izumi, H., Yoshida, S., Goto, D., Jimi, S. I., Kawahara, N., ... Kuwano, M. (1996). Angiogenesis as a new target for cancer treatment. Cancer Chemotherapy and Pharmacology, Supplement, 38.

Angiogenesis as a new target for cancer treatment. / Ono, Mayumi; Izumi, Hiroto; Yoshida, Shigeo; Goto, Daisuke; Jimi, Sei Ichiro; Kawahara, Naoyuki; Shono, Tadahisa; Ushiro, Shin; Ryuto, Masahiro; Kohno, Kimitoshi; Sato, Yasafumi; Kuwano, Michihiko.

In: Cancer Chemotherapy and Pharmacology, Supplement, Vol. 38, 23.08.1996.

Research output: Contribution to journalArticle

Ono, M, Izumi, H, Yoshida, S, Goto, D, Jimi, SI, Kawahara, N, Shono, T, Ushiro, S, Ryuto, M, Kohno, K, Sato, Y & Kuwano, M 1996, 'Angiogenesis as a new target for cancer treatment', Cancer Chemotherapy and Pharmacology, Supplement, vol. 38.
Ono M, Izumi H, Yoshida S, Goto D, Jimi SI, Kawahara N et al. Angiogenesis as a new target for cancer treatment. Cancer Chemotherapy and Pharmacology, Supplement. 1996 Aug 23;38.
Ono, Mayumi ; Izumi, Hiroto ; Yoshida, Shigeo ; Goto, Daisuke ; Jimi, Sei Ichiro ; Kawahara, Naoyuki ; Shono, Tadahisa ; Ushiro, Shin ; Ryuto, Masahiro ; Kohno, Kimitoshi ; Sato, Yasafumi ; Kuwano, Michihiko. / Angiogenesis as a new target for cancer treatment. In: Cancer Chemotherapy and Pharmacology, Supplement. 1996 ; Vol. 38.
@article{60c8dc34b0d243479dff973872b18898,
title = "Angiogenesis as a new target for cancer treatment",
abstract = "Neovascularization is often required for rapid growth of solid tumors and also limits vascular metastasis of tumor cells. Neovascularization-targeting agents are a recent innovation that may be a novel means of anticancer therapy. These antiangiogenic drugs have been developed by targeting cell proliferation of vascular endothelial cells, basement-membrane-degrading enzymes, angiogenic factors/receptors, extracellular matrix, angiogenesis signaling, and cell-cell/cell-matrix interactions. In this report, we describe how tumor angiogenesis occurs and how antiangiogenic agents are developed.",
author = "Mayumi Ono and Hiroto Izumi and Shigeo Yoshida and Daisuke Goto and Jimi, {Sei Ichiro} and Naoyuki Kawahara and Tadahisa Shono and Shin Ushiro and Masahiro Ryuto and Kimitoshi Kohno and Yasafumi Sato and Michihiko Kuwano",
year = "1996",
month = "8",
day = "23",
language = "English",
volume = "38",
journal = "Cancer Chemotherapy and Pharmacology, Supplement",
issn = "0943-9404",
publisher = "Springer Verlag",

}

TY - JOUR

T1 - Angiogenesis as a new target for cancer treatment

AU - Ono, Mayumi

AU - Izumi, Hiroto

AU - Yoshida, Shigeo

AU - Goto, Daisuke

AU - Jimi, Sei Ichiro

AU - Kawahara, Naoyuki

AU - Shono, Tadahisa

AU - Ushiro, Shin

AU - Ryuto, Masahiro

AU - Kohno, Kimitoshi

AU - Sato, Yasafumi

AU - Kuwano, Michihiko

PY - 1996/8/23

Y1 - 1996/8/23

N2 - Neovascularization is often required for rapid growth of solid tumors and also limits vascular metastasis of tumor cells. Neovascularization-targeting agents are a recent innovation that may be a novel means of anticancer therapy. These antiangiogenic drugs have been developed by targeting cell proliferation of vascular endothelial cells, basement-membrane-degrading enzymes, angiogenic factors/receptors, extracellular matrix, angiogenesis signaling, and cell-cell/cell-matrix interactions. In this report, we describe how tumor angiogenesis occurs and how antiangiogenic agents are developed.

AB - Neovascularization is often required for rapid growth of solid tumors and also limits vascular metastasis of tumor cells. Neovascularization-targeting agents are a recent innovation that may be a novel means of anticancer therapy. These antiangiogenic drugs have been developed by targeting cell proliferation of vascular endothelial cells, basement-membrane-degrading enzymes, angiogenic factors/receptors, extracellular matrix, angiogenesis signaling, and cell-cell/cell-matrix interactions. In this report, we describe how tumor angiogenesis occurs and how antiangiogenic agents are developed.

UR - http://www.scopus.com/inward/record.url?scp=0029811670&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029811670&partnerID=8YFLogxK

M3 - Article

VL - 38

JO - Cancer Chemotherapy and Pharmacology, Supplement

JF - Cancer Chemotherapy and Pharmacology, Supplement

SN - 0943-9404

ER -